HSBC Holdings
RLYB icon

HSBC Holdings’s Rallybio RLYB Stock Holding History

HSBC Holdings’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,315
Closed -$3.5K – 3069
2025
Q2 		$3.5K Sell
1,315
-192
-13% -$509 ﹤0.01% 3003
2025
Q1 		$7.89K Sell
1,507
-253
-14% -$1.6K ﹤0.01% 2993
2024
Q4 		$13K Hold
1,760
– – ﹤0.01% 3064
2024
Q3 		$16.2K Sell
1,760
-431
-20% -$4.15K ﹤0.01% 2954
2024
Q2 		$24.7K Buy
+2,191
New +$29.7K ﹤0.01% 2865
2024
Q1 		– Sell
-1,768
Closed -$33.7K – 3208
2023
Q4 		$33.7K Buy
+1,768
New +$43.2K ﹤0.01% 2670

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

HSBC Holdings's RLYB Position: Q3 2025 in Review

HSBC Holdings sold out of Rallybio (RLYB) in Q3 2025, closing a stake of 1,315 shares — an estimated $3.5K sold.

HSBC Holdings first reported a position in RLYB in Q4 2023 and held it in 6 quarters. The position peaked at $33.7K in Q4 2023. 45 funds tracked by Wall St. Rank hold RLYB as of Q3 2025.

  • HSBC Holdings reported no remaining Rallybio position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 1,315 Rallybio shares in Q3 2025, an estimated $3.5K.
  • HSBC Holdings first reported a position in Rallybio in Q4 2023 and held it in 6 quarters.
  • HSBC Holdings's Rallybio position peaked at $33.7K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Rallybio as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.